Assembled from the company's filings and exchange data as of today. Download PDF renders this page on the server; the narrative sections arrive with the Nexa composer.
Dossier · SHIVAM CHEMICALS LIMITED · 28 October 2026Page 1 of 3
Company Dossier
MarketPing Research · factual · no rating expressed
SHIVAM CHEMICALS LIMITED
BSE: 544165
Fast Moving Consumer Goods › Fast Moving Consumer Goods › Food Products › Animal Feed

SHIVAM CHEMICALS LIMITED

StateQ4 FY26 filed
Last close · 27 Oct 2026₹145.30
Market cap₹0.2k cr
TTM P/E · P/B · EV/EBITDA29.6 · — · —

Manufactures Hydrated Lime (Calcium Hydroxide) and distributes animal feed ingredients to Indian feed manufacturers. A newly leased Quick Lime manufacturing unit at Khimsar, Rajasthan is running at full capacity and supplies over 50% of the raw material needs of the company's wholly-owned subsidiary at Dahej, Gujarat, which has a 60,000 MT capacity for feed products. The feed ingredients portfolio covers Amino Acids and Feed Phosphates (sourced through supply partnerships in China and Morocco) and a customised Vitamin Premix product called 'Shivamin' sourced from Sri Lanka, with full launch in March 2026 after a June 2025 trial. The Khimsar unit and Dahej subsidiary together form a backward-integration push into the animal nutrition and feed ingredients space. FY26 consolidated revenue stood at Rs. 284.23 crore and standalone revenue at Rs. 269.56 crore. The company is listed on the BSE SME platform (Scrip Code 544165) since April 2024 following an Rs. 2,018 lakh IPO, and operates with a wholly-owned subsidiary called Shivam Chemicals and Minerals Pvt Ltd. AR · MarketPing reader · 2026-08-02

Revenue streams, as the annual report describes them. Hydrated Lime manufacturing, Animal feed ingredients distribution. Small-cap animal nutrition and lime manufacturer-distributor on BSE SME platform

What a broker report prints here — the analyst's thesis. This dossier prints the filed record instead; the narrative read of the latest results, the guidance ledger and the earnings-call summary are the composer's sections (INSTITUTIONAL-PLAN.md M3) and are not yet produced.

Exhibit 1: Financial summary, FY24–FY26 (all audited; no estimate years)

₹ crore · consolidatedFY24FY25FY26
Revenue147224284
EBITDA (ex other income)———
margin %———
Owners' profit———
EPS, as reported (₹)0.971.263.64
ROE % · ROCE %— · 13.8— · 11.9— · 21.7
Debt / equity (x)———
Cash from operations5(15)(6)
Capex—(1)(1)
Source: SEBI results XBRL as filed with BSE/NSE; EBITDA excludes other income.
Every figure is a filed number or a ratio over filed numbers · No rating, target or fair value is expressed · Disclosures on the last pagemarketping.in
Dossier · SHIVAM CHEMICALS LIMITED · 28 October 2026Page 2 of 3

Exhibit 2: Quarterly performance, last 5 quarters

₹ croreQ4 FY24Q2 FY25Q4 FY25Q2 FY26Q4 FY26
Revenue8294130132153
Profit before tax11235
Net profit—————
EPS (₹)0.580.340.911.162.49
Source: quarterly results as filed; the balance sheet is filed half-yearly and is not repeated here.

Exhibit 3: Peers — basic industry group, by market cap

CompanyM.cap ₹ crP/EP/BEV/EBITDAROE %ROCE %Rev CAGR 5y %EBITDA m. %
GODREJ AGROVET LIMITED11,22425.15.1913.220.617.610.38.9
AVANTI FEEDS LIMITED9,16917.32.479.717.723.58.19.0
MUKKA PROTEINS LIMITED74710.81.4110.510.812.8—10.1
KSE LTD.5630.81.61—24.030.5—(0.5)
SHIVAM CHEMICALS LIMITED ◆24729.6———17.8——
Mayank Cattle Food Limited638.3——————
AJOONI BIOTECH LIMITED5012.10.55—4.76.2—3.1
NARMADA AGROBASE LIMITED4457.5—————5.5
Source: exchange data and filed statements via the screener; multiples at current prices.

Exhibit 4: Where the company sits in its group

MetricCompanyGroup medianRankBetter than
P/E (TTM)29.614.77 of 814%
ROCE17.817.73 of 660%
Revenue growth85.451.83 of 660%
Market cap2474055 of 843%
Source: MarketPing peer ranks; a rank is a measurement, not a view.
Every figure is a filed number or a ratio over filed numbers · No rating, target or fair value is expressed · Disclosures on the last pagemarketping.in
Dossier · SHIVAM CHEMICALS LIMITED · 28 October 2026Page 3 of 3

Exhibit 5: Filings of the last 90 days, with the measured price reaction

Date · filingCategoryImportanceNext day %5-day %
16 Oct 2026 · Quarterly RTA certificate under SEBI Reg 74(5) for Q2 FY27complianceminimal——
2 Oct 2026 · Shivam Chemicals begins Feed-Grade DCP production at Dahej facilitybusiness updatesmedium——
28 Sept 2026 · Shivam Chemicals closes trading window from Oct 1 ahead of H1 FY27 resultscomplianceminimal——
22 Sept 2026 · 16th AGM: Both Resolutions Passed Unanimously by Shivam Chemicalsboard shareholder meetingslow——
21 Sept 2026 · Proceedings of 16th AGM held on 21 September 2026board shareholder meetingslow——
7 Sept 2026 · Shivam Chemicals restarts US biofuel feedstock exports, secures repeat ordersbusiness updatesmedium——
31 Aug 2026 · Book Closure Sept 14 to 21, 2026 for 16th AGMboard shareholder meetingslow——
30 Aug 2026 · 16th AGM notice filed; meeting on 21 Sept 2026board shareholder meetingslow——
30 Aug 2026 · Annual Report FY 2025-26 and 16th AGM Notice submitted to BSEboard shareholder meetingsmedium——
27 Aug 2026 · Board meeting outcome: AGM set for Sept 21, director up for rotationboard shareholder meetingslow——
Source: exchange announcements; each reaction is measured from the close before the filing. Next day = the close one session after the reaction day (the first session that could trade the filing).

How to read this document

Where a broker report showsThis document showsWhy
A rating (BUY / ADD / REDUCE / SELL)A state: the latest filed quarter and the measured reactionsan event is a fact; a rating is an opinion that requires SEBI RA registration
A target price and upsideThe current price and the multiples against the groupa target is a forecast; a multiple is a measurement
Estimate years marked EMore audited years; no estimatesMarketPing publishes no forecasts — your own model lives on the Models page

Sources, method and disclosures

This document is a statistical summary of publicly filed information and market data, prepared by software from primary sources: SEBI results XBRL filed with BSE and NSE, LODR disclosures, shareholding patterns, exchange price data. It contains no research recommendation, no price target and no opinion on the merits of any security, and is not a research report within the meaning of the SEBI (Research Analysts) Regulations, 2014, Regulation 2(1)(w)(vii). Financial statements are as filed (consolidated where the company files consolidated results). Ratios are computed over filed lines. Where a figure is unavailable the table shows a dash rather than an estimate. The business brief is written by MarketPing's reader from the annual report and checked against it; no figure in a table was generated by a model. Nothing here constitutes investment advice, an offer or a solicitation; readers should consult a SEBI-registered adviser before acting. MarketPing is not a SEBI-registered intermediary.

Every figure is a filed number or a ratio over filed numbers · No rating, target or fair value is expressed · Disclosures on the last pagemarketping.in